Covered recipient · General Payments record
YEWON KWAK
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2022–2024
$2,539.60
- Reported across 122 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,171.72 | 55 |
| Education | $99.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Celgene Corporation | $250.71 | 10 |
| ABBVIE INC. | $207.04 | 6 |
| Janssen Biotech, Inc. | $98.16 | 5 |
| Incyte Corporation | $81.64 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $52.48 | 2 |
| Janssen Scientific Affairs, LLC | $48.88 | 2 |
| SOBI, INC | $48.45 | 3 |
| Legend Biotech USA Inc. | $41.47 | 2 |
| Amgen Inc. | $39.15 | 2 |
| Karyopharm Therapeutics Inc. | $35.59 | 2 |
| JAZZ PHARMACEUTICALS INC. | $34.54 | 2 |
| GlaxoSmithKline, LLC. | $34.32 | 2 |
| SANOFI-AVENTIS U.S. LLC | $33.77 | 2 |
| Genmab U.S., Inc. | $31.54 | 1 |
| Merck Sharp & Dohme Corporation | $30.87 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $28.34 | 1 |
| Lilly USA, LLC | $21.58 | 1 |
| BeiGene USA, Inc. | $21.53 | 1 |
| Daiichi Sankyo Inc. | $20.63 | 1 |
| Rigel Pharmaceuticals, Inc. | $19.85 | 1 |
| GENZYME CORPORATION | $19.83 | 1 |
| Acrotech Biopharma Inc. | $18.97 | 1 |
| La Jolla Pharmaceutical Company | $18.73 | 1 |
| MorphoSys, US Inc. | $17.43 | 1 |
| PFIZER INC. | $15.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (56)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.